We describe opinions on medical use of Cannabis sativa L. under conditions of Slovakia (n = 717). Personal experience with marijuana was detected in 77.42% (n = 553) in age categories younger than 20 years (n = 96) and in 77.06% (n = 457) of adults. Almost 86% of respondents (n = 618) agreed with legal use of marijuana for medical purposes. Furthermore, respondents’ views on legal usage of marijuana for medical purposes could be affected by availability of information (r = .12) and personal experience (r = .23). Negative impact of substance abuse in younger age-groups was recognized as threat (r = .47), but knowledge about harmful effect of marijuana use did not affect personal opinion for decriminalization (r = .38).
American Academy of Pediatrics, Committee on Substance Abuse (1999) Marijuana: A continuing concern for pediatricians. Pediatrics104: 982–985.
2.
AnnasG. J. (2014) Medical marijuana, physicians, and state law. The New England Journal of Medicine371(11): 983–985.
3.
ArseneaultL.CannonM.MurrayR.CaspiA.MoffittT. E. (2002) Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal325: 1212–1213.
4.
AsbridgeM.HaydenJ. A.CartwrightJ. (2012) Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. British Medical Journal344: E536–E536.
5.
AshtonC. H.MooreP. (2011) Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatrica Scandinavica124: 250–261.
6.
AsoE.JuvésS.MaldonadoR.FerrerI. (2013) CB2 Cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice. Journal of Alzheimer’s Disease35(4): 847–858.
7.
BostwickJ.ReisfieldG.DuPontR. (2013) Clinical decisions. Medicinal use of marijuana. The New England Journal of Medicine368(9): 866–868.
8.
BoysA.FarrellM.TaylorC.MarsdenJ.GoodmanR.BrughaT.MeltzerH. (2003) Psychiatric morbidity and substance use in young people aged 13–15 years: Results from the child and adolescent survey of mental health. The British Journal of Psychiatry182: 509–517.
9.
CerdáM.WallM.KeyesK.GaleaS.HasinD. (2006) Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug and Alcohol Dependence120(1–3): 22–27.
10.
ChadwickB.MillerM.HurdY. (2013) Cannabis use during adolescent development: Susceptibility to psychiatric illness. Frontiers in Psychiatry4: 129.
11.
ChenC.O’BrienM.AnthonyJ. (2005) Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug and Alcohol Dependence79(1): 11–22.
12.
CoomberK.ToumbourouJ. W.MillerP.StaigerP. K.HemphillS. A.CatalanoR. F. (2011) Rural adolescent alcohol, tobacco, and illicit drug use: A comparison of students in Victoria, Australia, and Washington State, United States. The Journal of Rural Health27(4): 409–415. doi:10.1111/j.1748-0361.2010.00360.x.
13.
CroxfordJ. (2003) Therapeutic potential of Cannabinoids in CNS disease. CNS Drugs17(3): 179–202.
14.
DegenhardtL.HallW.LynskeyM. (2001) Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction96(11): 1603–1614.
FergussonD.HorwoodL. (1997) Early onset cannabis use and psychosocial adjustment in young adults. Addiction92(3): 279–296.
17.
FergussonD.HorwoodL. (2000) Cannabis use and dependence in a New Zealand birth cohort. The New Zealand Medical Journal113(1109): 156–158.
18.
FrieseB.GrubeJ. (2013) Legalization of medical marijuana and marijuana use among youths. Drugs: Education, Prevention, and Policy20(1): 33–39.
19.
GfroererJ. C.LarsonS. L.ColliverJ. D. (2007) Drug use patterns and trends in rural communities. The Journal of Rural Health23: 10–15. doi:10.1111/j.1748-0361.2007.00118.x.
20.
GordonA.ConleyJ.GordonJ. (2013) Medical consequences of marijuana use: A review of current literature. Current Psychiatry Reports15(12): 419–419.
21.
GrantI.AtkinsonJ.GouauxB.WilseyB. (2012) Medical marijuana: Clearing away the smoke. The Open Neurology Journal6: 18–25.
22.
GrotenhermenF.Müller-VahlK. (2012) The therapeutic potential of cannabis and cannabinoids. Deutsches Ärzteblatt international109(29–30): 495–501.
23.
HofmannM.FrazierC. (2013) Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. Experimental Neurology244: 43–50.
24.
JoffeA.YancyW.American Academy of Pediatrics Committee on Substance Abuse, & American Academy of Pediatrics Committee on Adolescence (2004) Legalization of marijuana: Potential impact on youth. Pediatrics113(6): E632–E638.
25.
JohnstonL.O’MalleyP.BachmanJ.SchulenbergJ. (2012) Monitoring the future: National results on adolescent drug use: Overview of key findings, 2011, Ann Arbor, MI: Institute of Social Research, The University of Michigan.
KralikovaE.KmetovaA.ZvolskaK.BlahaM.BortlicekZ. (2013) Czech adolescent smokers: Unhappy to smoke but unable to quit. The International Journal of Tuberculosis and Lung Disease17(6): 842–846.
28.
KresánekJ. (2010) Marijuana: Drug or healing plant? [Marijuana: “Droga” či liečivá rastlina?]. Lekarsky Obzor59(6): 237–238.
29.
Le FollB.TrigoJ.SharkeyK.Le StratY. (2013) Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?Medical Hypotheses80(5): 564–567.
30.
LeussinkV.HusseiniL.WarnkeC.BroussalisE.HartungH.KieseierB. (2012) Symptomatic therapy in multiple sclerosis: The role of cannabinoids in treating spasticity. Therapeutic Advances in Neurological Disorders5(5): 255–266.
31.
LewisB.HoffmanL. A.NixonS. J. (2014) Sex differences in drug use among polysubstance users. Drug and Alcohol Dependance145: 127–133. doi:10.1016/j.drugalcdep.2014.10.003.
32.
LjubotinaD.GalićJ.JukićV. (2004) Prevalence and risk factors of substance use among urban adolescents: Questionnaire study. Croatian Medical Journal45(1): 88–98.
33.
Lozano-OndouaA.WrightC.VardanyanA.KingT.Largent-MilnesT.NelsonM.VanderahT. (2010) A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. Life Sciences86(17): 18, 646–653.
34.
MartinoS. C.EllicksonP. L.McCaffreyD. F. (2008) Developmental trajectories of substance use from early to late adolescence: a comparison of rural and urban youth. Journal of Studies on Alcohol and Drugs69(3): 430–440.
35.
MatejovičováB.TrandžíkJ.SchlarmannováJ.BoledovičováM.VelemínskýM. (2015) Illegal drug use among female university students in Slovakia. Medical Science Monitor21: 254–261.
36.
MatherL.RauwendaalE.Moxham-HallV.WodakA. (2013) (Re)introducing medicinal cannabis. The Medical Journal of Australia199(1109): 759–761.
37.
O’ConnellT. J.Bou-MatarC. B. (2007) Long-term marijuana users seeking medical cannabis in California (2001-2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal4(16): 1–7.
38.
PazosM.SagredoO.Fernandez-RuizJ. (2008) The endocannabinoid system in Huntington’s disease. Current Pharmaceutical Design14(23): 2317–2325.
39.
ReingleJ.StarasS.JenningsW.BranchiniJ.Maldonado-MolinaM. (2012) The relationship between marijuana use and intimate partner violence in a nationally representative, longitudinal sample. Journal of Interpersonal Violence27(8): 1562–1578.
40.
RobsonP. (2014) Therapeutic potential of cannabinoid medicines. Drug Testing and Analysis6(1–2): 24–30.
41.
SwiftW.HallW.TeessonM. (2001) Cannabis use and dependence among Australian adults: Results from the national survey of mental health and wellbeing. Addiction96(5): 737–748.
42.
VickovicS. G.FradelaH. F. (2011) Medical marijuana in the news. The Southwest Journal of Criminal Justice8(1): 67–96.
43.
von SydowK.LiebR.PfisterH.HöflerM.SonntagH.WittchenH. (2001) The natural course of cannabis use, abuse and dependence over four years: A longitudinal community study of adolescents and young adults. Drug and Alcohol Dependence64(3): 347–361.
